Xuanzhu Bio-B (02575): The innovative drug Xuan Yuening® was included in the 2025 National Basic Medical Insurance Catalogue for the first time

Zhitongcaijing · 2d ago

According to the Zhitong Finance App, Xuanzhu Bio-B (02575) announced that the innovative drug Pyroxil tablets (product name: Xuan Yuening®) were included in the “National Basic Medical Insurance, Maternity Insurance and Work Injury Insurance Drug Catalogue (2025)” (2025 National Basic Medical Insurance Catalogue) for the first time. The 2025 national basic health insurance catalogue will be officially implemented on January 1, 2026.

The results of this medical insurance negotiation will help the company further improve the affordability and accessibility of Xuanyue Ning® among patients, further promote the drug's market promotion and increase sales scale, and have a positive impact on the company's long-term business development. The company will actively cooperate to promote the implementation of health insurance policies, continue to promote hospital access, expand the core market and expand market coverage, so as to continuously improve patients' access to medication.